Alternative dystrophin gene transcripts in golden retriever muscular dystrophy

被引:0
|
作者
Schatzberg, SJ
Anderson, LVB
Wilton, SD
Kornegay, JN
Mann, CJ
Solomon, GG
Sharp, NJH
机构
[1] N Carolina State Univ, Coll Vet Med, Raleigh, NC 27606 USA
[2] Newcastle Gen Hosp, Muscular Dystrophy Res Labs, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[3] Australian Neuromuscular Res Inst, Med Ctr, Nedlands, WA 6009, Australia
[4] Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA
关键词
Duchenne muscular dystrophy; golden retriever muscular dystrophy; dystrophin; alternative splicing; exon skipping;
D O I
10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.0.CO;2-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Golden retriever muscular dystrophy (GRMD), the canine model of Duchenne muscular dystrophy (DMD), is caused by a splice site mutation in the dystrophin gene. This mutation predicts a premature termination codon in exon 8 and a peptide that is 5% the size of normal dystrophin. Western blot analysis of skeletal muscle from GRMD dogs reveals a slightly truncated 390-kD protein that is approximately 91% the size of normal dystrophin. This 390-kD dystrophin suggests that GRMD dogs, like some DMD patients, employ a mechanism to overcome their predicted frameshift. Reverse-transcriptase polymerase chain reaction on GRMD muscle has revealed two in-frame dystrophin transcripts which lack either exons 3-9 or exons 5-12. Both transcripts could be translated into a dystrophin protein of approximately 390 kD. An understanding of how truncated dystrophin is produced in GRMD may allow this mechanism to be manipulated toward a potential therapy for DMD. (C) 1998 John Wiley & Sons, Inc.
引用
收藏
页码:991 / 998
页数:8
相关论文
共 50 条
  • [41] Splice Modification to Restore Functional Dystrophin Synthesis in Duchenne Muscular Dystrophy
    Wilton, Steve. D.
    Fletcher, Susan
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (08) : 988 - 1001
  • [42] Proximal dystrophin gene deletions and protein alterations in Becker muscular dystrophy
    Novakovic, I
    Bojic, D
    Todorovic, S
    Apostolski, S
    Lukovic, L
    Stefanovic, D
    Milasin, J
    BIOPHYSICS FROM MOLECULES TO BRAIN: IN MEMORY OF RADOSLAV K. ANDJUS, 2005, 1048 : 406 - 410
  • [43] Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
    Jacqueline N. Robinson-Hamm
    Charles A. Gersbach
    Human Genetics, 2016, 135 : 1029 - 1040
  • [44] Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy
    Ferrer, A
    Wells, KE
    Wells, DJ
    GENE THERAPY, 2000, 7 (17) : 1439 - 1446
  • [45] Muscular dystrophy in mice caused by two different alterations of dystrophin gene
    Rowinski, J
    Kozlowska, H
    Sulikowska-Rowinska, A
    Rejment, E
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 (02): : 119 - 120
  • [46] Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy
    A Ferrer
    K E Wells
    D J Wells
    Gene Therapy, 2000, 7 : 1439 - 1446
  • [47] DYSTROPHIN OR A RELATED PROTEIN IN DUCHENNE MUSCULAR-DYSTROPHY
    NICHOLSON, LVB
    JOHNSON, MA
    DAVISON, K
    ODONNELL, E
    FALKOUS, G
    BARRON, M
    HARRIS, JB
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (01): : 8 - 14
  • [48] Dystrophin Nonsense Mutations Can Generate Alternative Rescue Transcripts in Lymphocytes
    Nishiyama, A.
    Takeshima, Y.
    Zhang, Z.
    Habara, Y.
    Tran, T. H. T.
    Yagi, M.
    Matsuo, M.
    ANNALS OF HUMAN GENETICS, 2008, 72 : 717 - 724
  • [49] Gene therapy for Duchenne muscular dystrophy
    Suzuki, Naoki
    Miyagoe-Suzuki, Yuko
    Takeda, Shin'ichi
    FUTURE NEUROLOGY, 2007, 2 (01) : 87 - 96
  • [50] Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy
    Gaiad, T. P.
    Silva, M. B.
    Silva, G. C. A.
    Caromano, F. A.
    Miglino, M. A.
    Ambrosio, C. E.
    RESEARCH IN VETERINARY SCIENCE, 2011, 91 (02) : 188 - 193